Previous Events

08.05.2019 – The CRISPR Craze: A Gene Therapy ”Dream” come through?

crispr-cas9-gene-editing-1440x812

The nuclease-based gene editing tools such as meganucleases, zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas9 are rapidly transforming basic and biomedical research. Clearly, the simplicity and general access to CRISPR/Cas9 reagents has democratized the conduct of precise genome targeting in cells, tissues, organs, and whole animals. This presentation will give a brief historic outline of the genome editing events that led to the “CRISPR craze” and display some of the basic concepts of CRISPR/Cas9 mediated gene editing.

These concepts include optimal strategies for design, delivery and detection of Cas9 gene editing. Taken together, these concepts and principles show great promise, may provide for rapid translation of basic research from “bench to bedside” and are expected to pave the way for the next generation gene therapies.

Keynote speaker:

Eric P. Bennett has obtained both his master degree in Biochemistry and Molecular Biology (MSc) and doctoral degree (Dr.med) from the University of Copenhagen. His research efforts at the Copenhagen Center for Glycomics (University of Copenhagen) have been concentrated in the field of Glycobiology where he has cloned and identified more than 30 human glycosyltransferase encoded genes (glycogenes). For the last 9 years his efforts have been focused on ways of establishing precision-engineered isogenic cells lacking individual glycogenes. Using the recently emerged nuclease targeting technologies, such as ZFN, TALEN and CRISPR/Cas9, these efforts have among others led to establishment of novel methodologies that both improve the targeting and indel detection efficacy of precise gene targeting. The methods and principles developed show great translational potential into the biotech and therapeutic genome targeting space.

25.04.2019 Cancer, Cancer Research and Immunotherapy

Baggrund 1

Cancer research is a growing field focusing on identifying causes of cancer as well as developing strategies for prevention, diagnosis, treatment and cure. The research ranges from epidemiology, molecular bioscience to clinical trials, and is therefore highly interdisciplinary. Today’s treatment includes surgery, radiation therapy, chemotherapy, hormone therapy and immunotherapy, but cancer research is in constant development, and in the later years the research focus has shifted towards therapies derived from biotechnology, such as gene therapy and cancer immunotherapy. 

At this event the focus will be on cancer research taking place in the Copenhagen area including the University of Copenhagen, The Danish Cancer research Society (Kræftens Bekæmpelse) and the National Center for Cancer Immune Therapy at Herlev Hospital. 

Speakers: 

Skærmbillede 2019-03-31 kl. 17.28.47.pngIn 2017 The Danish Cancer Society was declared the strongest cancer research center in the world. Here Dr. Lisa Frankel,  group leader for RNA and Autophagy, works with the understanding of  fundamental mechanism in mammalian cells, and investigates how these become perturbed in the development of cancer. The group mainly focusses on autophagy, particularly the interplay between RNA, translation and autophagy.

 

Skærmbillede 2019-03-31 kl. 17.57.13.png

At The National Center for Cancer Immune Therapy (CCIT) they have established groundbreaking immunotherapy to patients, and are pioneers in Denmark and  Europe in modulating the different parts of the immune system in order to combat cancer.  At this event PhD Fellows Kasper Mølgaard Jensen will give an insight into how CCIT exploits parts of the immune system to fight cancer.

 

Skærmbillede 2019-03-31 kl. 17.54.22.pngAt The Department of Biology at the University of Copenhagen group leader for the NHE1 group, Prof. Stine Falsig Pedersen, focuses her research on the regulation of ion transport proteins with a focus on their roles in cancer development.

 

23.11.2018 Bioscience Project Day 2018

Having a hard time finding the right Bachelor project? Looking for inspiration for your Master’s Thesis? Want to learn more about what your options are, or maybe even considered doing a project in the industry?
Biologisk Fagråd, Biokemisk Fagråd, Forening af Biologi-Bioteknologi studerende and Coetus Denmark have put their heads together to make an interdisciplinary project day for Bioscience students in the Copenhagen area.

This day will be featuring professors from the different study directions and institutes as well as researcher from the industry, whom are looking for students to do a project in their laboratory. This will be a great opportunity to learn about the possibilities outside (or even inside) your own curriculum.

16.05.2018 Neuropharmacology

FORENSIC FOR WEB

Have you ever wondered how the chemicals we consume affect our brain? Why cocaine makes people feel like they are flying, or antidepressants are able to alleviate feelings of depression and anxiety?

The study of Neuropharmacology focuses on the way drugs affects the nervous system and the neural mechanism. On a molecular level this involves the study of neurons and their neurochemical interactions with the aim to develop the most neurological beneficial drugs and archive a higher understanding of neurodegenerative diseases and psychological disorders.

At this event associate professor Claus Løland will give us a short introduction to how the brain and nerve cells function, and give us an insight into the field of neuropharmacology and his research. At the Løland lab they work with structure-function relationships in membrane transporters, with a particularly emphasis on the Sodium Symporter class of proteins. As part of this they focus on identifying domains undergoing conformational changes during substrate binding and translocation. In addition, they map the binding sites and binding modes for inhibitory drug such as cocaine and antidepressant, as well substrates e.g. dopamine and amphetamine.

This research combines methods from advanced biophysics, biochemistry and molecular pharmacology.

02.05.2018 Synthetic Biology

Alger

Synthetic Biology is a new interdisciplinary field within biology in which basic engineering principles are applied to biological systems. It brings together several aspects from other domains such as biotechnology, genetic engineering, molecular biology and biochemistry with the overall purpose of building artificial biological systems for research, engineering and medical applications. The key concept in synthetic biology is standardization of biological parts, achieved by basic technologies such as standardized DNA parts (So-called Biobricks), DNA synthesis, modular protein assemblies as well as modeling.
Although synthetic biology is an upcoming field it is still quite undefined and not very well-known among researcher and student in Denmark.
Speakers: Tomas Laursen is Postdoc in Plant Biochemistry at the department of Plant and Environmental Sciences and currently researching a complex system of “powertool”-proteins located in the membranes of the cells, with the purpose to investigate the relationship between conformational changes of cytochrome P450 reductase and its electron transfer action, providing an understanding on how to regulate the enzyme.

 21.03.2018 Carlsberg Research Laboratory

 carlsberg-group_rgb-copy

Since 1875 the Carlsberg Research Laboratory have received international acknowledgement for their eminent and groundbreaking research which have had a great influence on many scientific fields, particular in bioscience. Some of the most prominent research includes creating a method for quantification of nitrogen in organic compounds, introducing the concept of pH, and revolutionary proteinchemistry research (in particular about proteolytic enzymes and the dynamic nature of proteins).

Today the Carlsberg research laboratory is split into 4 groups of interdisciplinary teams combining expertise in brewing science, chemistry, biochemistry, physiology, genetics, bioinformatics, and  in molecular biology. These teams form the Carlsberg groups, all working  together to further perfect the art of brewing. This event will highlight both previous and current research, as well as the possibilities for jobs and projects within this industry.

Keynote speaker:

Jochen Förster have worked as Director and Professor for Yeast and Fermentation at Carlsberg Groups since 2016. Here he works with the creation of new brewing organisms with improved traits for application in their core-, speciality- and non-alcoholic beers.

07.03.2018 The Gut Microbiota

gut microbiome

The human microbiota is composed of a wide array of microorganisms with roots within all domains of life. Today these microbes are acknowledged for having a tremendous impact on our physiology – as well as our psychological behavior – as they provide us with everything from new metabolic functions and pathogen protection, to education for our immune systems.

In 2016 the ratio of human to microbial cells in the average human body was estimated to be around 1:1. With only a limited amount of the microbes living inside us having been cultured and studied, there is still much research to be undertaken on the microbes taking residence within our bodies. Karsten Kristiansen, professor and head of Laboratory of Genome Research and Molecular Bio Medicine at University of Copenhagen as well as professor and Director of Institute of Metagenomics at BGI-Shenzhen, will be giving us an insight into his research in Copenhagen and Shenzhen. In addition he will provide information about projects and career paths in this rising new field.

21.02.2018 Biosynthia – An insight into an upcoming biotech company

Biosyntia-x2
What if you could easily make natural compounds such as vitamins using organic synthesis? Not only could you reduce the cost of production, but you could also obtain a higher quality of your solutions as well as reduce the environmental impact compared to chemical synthesis.

One company had that vision, Biosynthia. Having raised more than 6 millions USD and received several recognitions, including being one of the most innovative SNMEs in Europe, Biosynthia is today one of the most up and coming biotechnological companies.

Co-founder and CSO Hans Genee will, together with a Ph.D student at Biosynthia, give us an insight into who Biosynthia is and their current research. In addition they will also talk about how it is to write a Ph.D – or a project – at Biosynthia and what it takes.

is today one of the most upcoming biotechnology companies.

07.02.2018 Bioentreprenuership

160726_dummy_image16_9_6743_1
What does it take to become a successful entrepreneur, and how do you go from idea to business?
Denmark is today one of the best countries to in which to become an entrepreneur making it an attractive career for students. However knowing how to do start up on your own, and maintain the necessary drive and motivation can be a rather difficult task.
Anne Sophie Vinther Hansen started her journey as a serial entrepreneur at the age of 11 and continued all the way through her studies culminating in the bio company Cumulus Bio which last year was granted 30 million Danish Krones from Innovationsfonden. Today she is working as the Head of investments at Syddansk Innovation. In this kick-off event she will be giving an inspirational talk on her experiences.

Read more about event on Facebook here.